Fusion Pharmaceuticals Inc. Interest Receivable
Fusion Pharmaceuticals Inc. had Interest Receivable of $1.34 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Assets
us-gaap:InterestReceivable · last filed 2024-05-07
- 2024-03-31: Interest Receivable $1.34M.
- 2023-12-31: Interest Receivable $822.00K.
- 2023-09-30: Interest Receivable $716.00K.
- 2023-06-30: Interest Receivable $688.00K.
| Period end | Interest Receivable |
|---|---|
| 2024-03-31 | $1.34M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $822.00K 10-Q · filed 2024-05-07 |
| 2023-09-30 | $716.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $688.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $591.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $332.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | $107.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $251.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $231.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $350.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $461.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $575.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $548.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $504.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $229.00K 10-Q · filed 2020-11-10 |
| 2019-12-31 | $62.00K 10-K · filed 2021-03-25 |